Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Even as Republican presidential candidates vow to dismantle what they call "Obamacare" -- the Patient Protection and Affordable Care Act of 2010 -- some of the law's key provisions are making their way onto the medical landscape. The latest step toward implementing the law came Thursday, as the Food and Drug Administration issued draft rules that will open the U.S. marketplace to "biosimilars" -- essentially generic versions of medications made with living, often bioengineered, organisms.
The FDA's actions Thursday promise U.S. consumers the prospect of big savings and some uncertainty too, as generic drug manufacturers and biotechnology firms -- many of them outside of the United States -- begin to make and market these complex medications.
http://www.latimes.com/health/boost...-obamacare-20120209,0,5168122.story?track=rss
The FDA's actions Thursday promise U.S. consumers the prospect of big savings and some uncertainty too, as generic drug manufacturers and biotechnology firms -- many of them outside of the United States -- begin to make and market these complex medications.
http://www.latimes.com/health/boost...-obamacare-20120209,0,5168122.story?track=rss